Global Drug Developing Platforms by Artificial Intelligence (AI) Market Insights, Forecast to 2029
This report presents an overview of global market for Drug Developing Platforms by Artificial Intelligence (AI) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Drug Developing Platforms by Artificial Intelligence (AI), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Developing Platforms by Artificial Intelligence (AI), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Developing Platforms by Artificial Intelligence (AI) revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Drug Developing Platforms by Artificial Intelligence (AI) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Drug Developing Platforms by Artificial Intelligence (AI) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, Row Analytics, Deep Genomics, Insilico Medicine, IBM and Microsoft, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Developing Platforms by Artificial Intelligence (AI) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Developing Platforms by Artificial Intelligence (AI) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Developing Platforms by Artificial Intelligence (AI) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Drug Developing Platforms by Artificial Intelligence (AI), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Developing Platforms by Artificial Intelligence (AI), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Developing Platforms by Artificial Intelligence (AI) revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Drug Developing Platforms by Artificial Intelligence (AI) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Drug Developing Platforms by Artificial Intelligence (AI) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Antidote, Atomwise, Turbine, Cambridge Cancer Genomics, Row Analytics, Deep Genomics, Insilico Medicine, IBM and Microsoft, etc.
By Company
- Antidote
- Atomwise
- Turbine
- Cambridge Cancer Genomics
- Row Analytics
- Deep Genomics
- Insilico Medicine
- IBM
- Microsoft
- AiCure
- Calico
- Iktos
- GNS Healthcare
- Genpact
- Biovista
- NuMedii
- BenevolentAI
- BERG
- Schrцdinge
- Nuritas
- Exscientia
- Kairntech
- Concerto HealthAI (SymphonyAI)
- NVIDIA Corporation
- Sirenas
- Standigm
- Transcriptic
- Cloud Pharmaceuticals
- Cyclica
- Software
- System
- Service
- Product
- Others
- Generate Data and Models
- Repurpose Existing Drugs
- Generate Novel Drug Candidates
- Validate and Optimize Drug Candidates
- Design Drugs
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Developing Platforms by Artificial Intelligence (AI) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Developing Platforms by Artificial Intelligence (AI) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Developing Platforms by Artificial Intelligence (AI) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Software
1.2.3 System
1.2.4 Service
1.2.5 Product
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Generate Data and Models
1.3.3 Repurpose Existing Drugs
1.3.4 Generate Novel Drug Candidates
1.3.5 Validate and Optimize Drug Candidates
1.3.6 Design Drugs
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Perspective (2018-2029)
2.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Growth Trends by Region
2.2.1 Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Region (2018-2023)
2.2.3 Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Region (2024-2029)
2.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Dynamics
2.3.1 Drug Developing Platforms by Artificial Intelligence (AI) Industry Trends
2.3.2 Drug Developing Platforms by Artificial Intelligence (AI) Market Drivers
2.3.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Challenges
2.3.4 Drug Developing Platforms by Artificial Intelligence (AI) Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Drug Developing Platforms by Artificial Intelligence (AI) by Players
3.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue by Players (2018-2023)
3.1.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Players (2018-2023)
3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio
3.4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Developing Platforms by Artificial Intelligence (AI) Revenue in 2022
3.5 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI) Head office and Area Served
3.6 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Product and Application
3.7 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DRUG DEVELOPING PLATFORMS BY ARTIFICIAL INTELLIGENCE (AI) BREAKDOWN DATA BY TYPE
4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Type (2018-2023)
4.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Type (2024-2029)
5 DRUG DEVELOPING PLATFORMS BY ARTIFICIAL INTELLIGENCE (AI) BREAKDOWN DATA BY APPLICATION
5.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Application (2018-2023)
5.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
6.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
6.2.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
6.2.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
6.2.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
6.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
6.3.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
6.3.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
6.3.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
6.4 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
6.4.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
6.4.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
7.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
7.2.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
7.2.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
7.2.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
7.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
7.3.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
7.3.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
7.3.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
7.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
7.4.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
7.4.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
8.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
8.2.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
8.2.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
8.2.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
8.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
8.3.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
8.3.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
8.3.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
9.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
9.2.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
9.2.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
9.2.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
9.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
9.3.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
9.3.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
9.3.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
9.4 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region
9.4.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2018-2023)
9.4.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Antidote
11.1.1 Antidote Company Details
11.1.2 Antidote Business Overview
11.1.3 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.1.4 Antidote Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.1.5 Antidote Recent Developments
11.2 Atomwise
11.2.1 Atomwise Company Details
11.2.2 Atomwise Business Overview
11.2.3 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.2.4 Atomwise Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.2.5 Atomwise Recent Developments
11.3 Turbine
11.3.1 Turbine Company Details
11.3.2 Turbine Business Overview
11.3.3 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.3.4 Turbine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.3.5 Turbine Recent Developments
11.4 Cambridge Cancer Genomics
11.4.1 Cambridge Cancer Genomics Company Details
11.4.2 Cambridge Cancer Genomics Business Overview
11.4.3 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.4.4 Cambridge Cancer Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.4.5 Cambridge Cancer Genomics Recent Developments
11.5 Row Analytics
11.5.1 Row Analytics Company Details
11.5.2 Row Analytics Business Overview
11.5.3 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.5.4 Row Analytics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.5.5 Row Analytics Recent Developments
11.6 Deep Genomics
11.6.1 Deep Genomics Company Details
11.6.2 Deep Genomics Business Overview
11.6.3 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.6.4 Deep Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.6.5 Deep Genomics Recent Developments
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Details
11.7.2 Insilico Medicine Business Overview
11.7.3 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.7.4 Insilico Medicine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.7.5 Insilico Medicine Recent Developments
11.8 IBM
11.8.1 IBM Company Details
11.8.2 IBM Business Overview
11.8.3 IBM Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.8.4 IBM Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.8.5 IBM Recent Developments
11.9 Microsoft
11.9.1 Microsoft Company Details
11.9.2 Microsoft Business Overview
11.9.3 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.9.4 Microsoft Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.9.5 Microsoft Recent Developments
11.10 Google
11.10.1 Google Company Details
11.10.2 Google Business Overview
11.10.3 Google Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.10.4 Google Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.10.5 Google Recent Developments
11.11 AiCure
11.11.1 AiCure Company Details
11.11.2 AiCure Business Overview
11.11.3 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.11.4 AiCure Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.11.5 AiCure Recent Developments
11.12 Calico
11.12.1 Calico Company Details
11.12.2 Calico Business Overview
11.12.3 Calico Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.12.4 Calico Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.12.5 Calico Recent Developments
11.13 Iktos
11.13.1 Iktos Company Details
11.13.2 Iktos Business Overview
11.13.3 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.13.4 Iktos Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.13.5 Iktos Recent Developments
11.14 GNS Healthcare
11.14.1 GNS Healthcare Company Details
11.14.2 GNS Healthcare Business Overview
11.14.3 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.14.4 GNS Healthcare Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.14.5 GNS Healthcare Recent Developments
11.15 Genpact
11.15.1 Genpact Company Details
11.15.2 Genpact Business Overview
11.15.3 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.15.4 Genpact Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.15.5 Genpact Recent Developments
11.16 Biovista
11.16.1 Biovista Company Details
11.16.2 Biovista Business Overview
11.16.3 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.16.4 Biovista Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.16.5 Biovista Recent Developments
11.17 NuMedii
11.17.1 NuMedii Company Details
11.17.2 NuMedii Business Overview
11.17.3 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.17.4 NuMedii Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.17.5 NuMedii Recent Developments
11.18 BenevolentAI
11.18.1 BenevolentAI Company Details
11.18.2 BenevolentAI Business Overview
11.18.3 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.18.4 BenevolentAI Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.18.5 BenevolentAI Recent Developments
11.19 BERG
11.19.1 BERG Company Details
11.19.2 BERG Business Overview
11.19.3 BERG Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.19.4 BERG Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.19.5 BERG Recent Developments
11.20 Schrцdinge
11.20.1 Schrцdinge Company Details
11.20.2 Schrцdinge Business Overview
11.20.3 Schrцdinge Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.20.4 Schrцdinge Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.20.5 Schrцdinge Recent Developments
11.21 Nuritas
11.21.1 Nuritas Company Details
11.21.2 Nuritas Business Overview
11.21.3 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.21.4 Nuritas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.21.5 Nuritas Recent Developments
11.22 Exscientia
11.22.1 Exscientia Company Details
11.22.2 Exscientia Business Overview
11.22.3 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.22.4 Exscientia Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.22.5 Exscientia Recent Developments
11.23 Kairntech
11.23.1 Kairntech Company Details
11.23.2 Kairntech Business Overview
11.23.3 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.23.4 Kairntech Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.23.5 Kairntech Recent Developments
11.24 Concerto HealthAI (SymphonyAI)
11.24.1 Concerto HealthAI (SymphonyAI) Company Details
11.24.2 Concerto HealthAI (SymphonyAI) Business Overview
11.24.3 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.24.4 Concerto HealthAI (SymphonyAI) Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.24.5 Concerto HealthAI (SymphonyAI) Recent Developments
11.25 NVIDIA Corporation
11.25.1 NVIDIA Corporation Company Details
11.25.2 NVIDIA Corporation Business Overview
11.25.3 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.25.4 NVIDIA Corporation Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.25.5 NVIDIA Corporation Recent Developments
11.26 Sirenas
11.26.1 Sirenas Company Details
11.26.2 Sirenas Business Overview
11.26.3 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.26.4 Sirenas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.26.5 Sirenas Recent Developments
11.27 Standigm
11.27.1 Standigm Company Details
11.27.2 Standigm Business Overview
11.27.3 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.27.4 Standigm Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.27.5 Standigm Recent Developments
11.28 Transcriptic
11.28.1 Transcriptic Company Details
11.28.2 Transcriptic Business Overview
11.28.3 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.28.4 Transcriptic Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.28.5 Transcriptic Recent Developments
11.29 Cloud Pharmaceuticals
11.29.1 Cloud Pharmaceuticals Company Details
11.29.2 Cloud Pharmaceuticals Business Overview
11.29.3 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.29.4 Cloud Pharmaceuticals Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.29.5 Cloud Pharmaceuticals Recent Developments
11.30 Cyclica
11.30.1 Cyclica Company Details
11.30.2 Cyclica Business Overview
11.30.3 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.30.4 Cyclica Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.30.5 Cyclica Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Software
1.2.3 System
1.2.4 Service
1.2.5 Product
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Generate Data and Models
1.3.3 Repurpose Existing Drugs
1.3.4 Generate Novel Drug Candidates
1.3.5 Validate and Optimize Drug Candidates
1.3.6 Design Drugs
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Perspective (2018-2029)
2.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Growth Trends by Region
2.2.1 Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Region (2018-2023)
2.2.3 Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Region (2024-2029)
2.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Dynamics
2.3.1 Drug Developing Platforms by Artificial Intelligence (AI) Industry Trends
2.3.2 Drug Developing Platforms by Artificial Intelligence (AI) Market Drivers
2.3.3 Drug Developing Platforms by Artificial Intelligence (AI) Market Challenges
2.3.4 Drug Developing Platforms by Artificial Intelligence (AI) Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Drug Developing Platforms by Artificial Intelligence (AI) by Players
3.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue by Players (2018-2023)
3.1.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Players (2018-2023)
3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio
3.4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Developing Platforms by Artificial Intelligence (AI) Revenue in 2022
3.5 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI) Head office and Area Served
3.6 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Product and Application
3.7 Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DRUG DEVELOPING PLATFORMS BY ARTIFICIAL INTELLIGENCE (AI) BREAKDOWN DATA BY TYPE
4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Type (2018-2023)
4.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Type (2024-2029)
5 DRUG DEVELOPING PLATFORMS BY ARTIFICIAL INTELLIGENCE (AI) BREAKDOWN DATA BY APPLICATION
5.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Historic Market Size by Application (2018-2023)
5.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
6.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
6.2.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
6.2.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
6.2.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
6.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
6.3.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
6.3.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
6.3.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
6.4 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
6.4.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
6.4.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
7.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
7.2.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
7.2.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
7.2.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
7.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
7.3.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
7.3.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
7.3.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
7.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
7.4.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
7.4.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
8.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
8.2.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
8.2.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
8.2.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
8.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
8.3.1 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
8.3.2 China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
8.3.3 China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
9.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
9.2.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
9.2.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
9.2.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
9.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
9.3.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
9.3.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
9.3.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
9.4 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region
9.4.1 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2018-2023)
9.4.3 Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Antidote
11.1.1 Antidote Company Details
11.1.2 Antidote Business Overview
11.1.3 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.1.4 Antidote Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.1.5 Antidote Recent Developments
11.2 Atomwise
11.2.1 Atomwise Company Details
11.2.2 Atomwise Business Overview
11.2.3 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.2.4 Atomwise Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.2.5 Atomwise Recent Developments
11.3 Turbine
11.3.1 Turbine Company Details
11.3.2 Turbine Business Overview
11.3.3 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.3.4 Turbine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.3.5 Turbine Recent Developments
11.4 Cambridge Cancer Genomics
11.4.1 Cambridge Cancer Genomics Company Details
11.4.2 Cambridge Cancer Genomics Business Overview
11.4.3 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.4.4 Cambridge Cancer Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.4.5 Cambridge Cancer Genomics Recent Developments
11.5 Row Analytics
11.5.1 Row Analytics Company Details
11.5.2 Row Analytics Business Overview
11.5.3 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.5.4 Row Analytics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.5.5 Row Analytics Recent Developments
11.6 Deep Genomics
11.6.1 Deep Genomics Company Details
11.6.2 Deep Genomics Business Overview
11.6.3 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.6.4 Deep Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.6.5 Deep Genomics Recent Developments
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Details
11.7.2 Insilico Medicine Business Overview
11.7.3 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.7.4 Insilico Medicine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.7.5 Insilico Medicine Recent Developments
11.8 IBM
11.8.1 IBM Company Details
11.8.2 IBM Business Overview
11.8.3 IBM Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.8.4 IBM Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.8.5 IBM Recent Developments
11.9 Microsoft
11.9.1 Microsoft Company Details
11.9.2 Microsoft Business Overview
11.9.3 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.9.4 Microsoft Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.9.5 Microsoft Recent Developments
11.10 Google
11.10.1 Google Company Details
11.10.2 Google Business Overview
11.10.3 Google Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.10.4 Google Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.10.5 Google Recent Developments
11.11 AiCure
11.11.1 AiCure Company Details
11.11.2 AiCure Business Overview
11.11.3 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.11.4 AiCure Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.11.5 AiCure Recent Developments
11.12 Calico
11.12.1 Calico Company Details
11.12.2 Calico Business Overview
11.12.3 Calico Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.12.4 Calico Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.12.5 Calico Recent Developments
11.13 Iktos
11.13.1 Iktos Company Details
11.13.2 Iktos Business Overview
11.13.3 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.13.4 Iktos Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.13.5 Iktos Recent Developments
11.14 GNS Healthcare
11.14.1 GNS Healthcare Company Details
11.14.2 GNS Healthcare Business Overview
11.14.3 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.14.4 GNS Healthcare Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.14.5 GNS Healthcare Recent Developments
11.15 Genpact
11.15.1 Genpact Company Details
11.15.2 Genpact Business Overview
11.15.3 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.15.4 Genpact Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.15.5 Genpact Recent Developments
11.16 Biovista
11.16.1 Biovista Company Details
11.16.2 Biovista Business Overview
11.16.3 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.16.4 Biovista Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.16.5 Biovista Recent Developments
11.17 NuMedii
11.17.1 NuMedii Company Details
11.17.2 NuMedii Business Overview
11.17.3 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.17.4 NuMedii Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.17.5 NuMedii Recent Developments
11.18 BenevolentAI
11.18.1 BenevolentAI Company Details
11.18.2 BenevolentAI Business Overview
11.18.3 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.18.4 BenevolentAI Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.18.5 BenevolentAI Recent Developments
11.19 BERG
11.19.1 BERG Company Details
11.19.2 BERG Business Overview
11.19.3 BERG Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.19.4 BERG Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.19.5 BERG Recent Developments
11.20 Schrцdinge
11.20.1 Schrцdinge Company Details
11.20.2 Schrцdinge Business Overview
11.20.3 Schrцdinge Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.20.4 Schrцdinge Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.20.5 Schrцdinge Recent Developments
11.21 Nuritas
11.21.1 Nuritas Company Details
11.21.2 Nuritas Business Overview
11.21.3 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.21.4 Nuritas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.21.5 Nuritas Recent Developments
11.22 Exscientia
11.22.1 Exscientia Company Details
11.22.2 Exscientia Business Overview
11.22.3 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.22.4 Exscientia Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.22.5 Exscientia Recent Developments
11.23 Kairntech
11.23.1 Kairntech Company Details
11.23.2 Kairntech Business Overview
11.23.3 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.23.4 Kairntech Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.23.5 Kairntech Recent Developments
11.24 Concerto HealthAI (SymphonyAI)
11.24.1 Concerto HealthAI (SymphonyAI) Company Details
11.24.2 Concerto HealthAI (SymphonyAI) Business Overview
11.24.3 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.24.4 Concerto HealthAI (SymphonyAI) Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.24.5 Concerto HealthAI (SymphonyAI) Recent Developments
11.25 NVIDIA Corporation
11.25.1 NVIDIA Corporation Company Details
11.25.2 NVIDIA Corporation Business Overview
11.25.3 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.25.4 NVIDIA Corporation Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.25.5 NVIDIA Corporation Recent Developments
11.26 Sirenas
11.26.1 Sirenas Company Details
11.26.2 Sirenas Business Overview
11.26.3 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.26.4 Sirenas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.26.5 Sirenas Recent Developments
11.27 Standigm
11.27.1 Standigm Company Details
11.27.2 Standigm Business Overview
11.27.3 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.27.4 Standigm Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.27.5 Standigm Recent Developments
11.28 Transcriptic
11.28.1 Transcriptic Company Details
11.28.2 Transcriptic Business Overview
11.28.3 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.28.4 Transcriptic Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.28.5 Transcriptic Recent Developments
11.29 Cloud Pharmaceuticals
11.29.1 Cloud Pharmaceuticals Company Details
11.29.2 Cloud Pharmaceuticals Business Overview
11.29.3 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.29.4 Cloud Pharmaceuticals Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.29.5 Cloud Pharmaceuticals Recent Developments
11.30 Cyclica
11.30.1 Cyclica Company Details
11.30.2 Cyclica Business Overview
11.30.3 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Introduction
11.30.4 Cyclica Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
11.30.5 Cyclica Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Software
Table 3. Key Players of System
Table 4. Key Players of Service
Table 5. Key Players of Product
Table 6. Key Players of Others
Table 7. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region (2018-2023)
Table 11. Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region (2024-2029)
Table 13. Drug Developing Platforms by Artificial Intelligence (AI) Market Trends
Table 14. Drug Developing Platforms by Artificial Intelligence (AI) Market Drivers
Table 15. Drug Developing Platforms by Artificial Intelligence (AI) Market Challenges
Table 16. Drug Developing Platforms by Artificial Intelligence (AI) Market Restraints
Table 17. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Share by Players (2018-2023)
Table 19. Global Top Drug Developing Platforms by Artificial Intelligence (AI) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Developing Platforms by Artificial Intelligence (AI) as of 2022)
Table 20. Global Drug Developing Platforms by Artificial Intelligence (AI) Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Drug Developing Platforms by Artificial Intelligence (AI) Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Headquarters and Area Served
Table 23. Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Product and Application
Table 24. Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Type (2018-2023)
Table 28. Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Type (2024-2029)
Table 30. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Share by Application (2018-2023)
Table 32. Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Share by Application (2024-2029)
Table 34. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029) & (US$ Million)
Table 66. Antidote Company Details
Table 67. Antidote Business Overview
Table 68. Antidote Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 69. Antidote Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 70. Antidote Recent Developments
Table 71. Atomwise Company Details
Table 72. Atomwise Business Overview
Table 73. Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 74. Atomwise Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 75. Atomwise Recent Developments
Table 76. Turbine Company Details
Table 77. Turbine Business Overview
Table 78. Turbine Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 79. Turbine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 80. Turbine Recent Developments
Table 81. Cambridge Cancer Genomics Company Details
Table 82. Cambridge Cancer Genomics Business Overview
Table 83. Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 84. Cambridge Cancer Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 85. Cambridge Cancer Genomics Recent Developments
Table 86. Row Analytics Company Details
Table 87. Row Analytics Business Overview
Table 88. Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 89. Row Analytics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 90. Row Analytics Recent Developments
Table 91. Deep Genomics Company Details
Table 92. Deep Genomics Business Overview
Table 93. Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 94. Deep Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 95. Deep Genomics Recent Developments
Table 96. Insilico Medicine Company Details
Table 97. Insilico Medicine Business Overview
Table 98. Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 99. Insilico Medicine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 100. Insilico Medicine Recent Developments
Table 101. IBM Company Details
Table 102. IBM Business Overview
Table 103. IBM Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 104. IBM Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 105. IBM Recent Developments
Table 106. Microsoft Company Details
Table 107. Microsoft Business Overview
Table 108. Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 109. Microsoft Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 110. Microsoft Recent Developments
Table 111. Google Company Details
Table 112. Google Business Overview
Table 113. Google Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 114. Google Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 115. Google Recent Developments
Table 116. AiCure Company Details
Table 117. AiCure Business Overview
Table 118. AiCure Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 119. AiCure Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 120. AiCure Recent Developments
Table 121. Calico Company Details
Table 122. Calico Business Overview
Table 123. Calico Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 124. Calico Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 125. Calico Recent Developments
Table 126. Iktos Company Details
Table 127. Iktos Business Overview
Table 128. Iktos Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 129. Iktos Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 130. Iktos Recent Developments
Table 131. GNS Healthcare Company Details
Table 132. GNS Healthcare Business Overview
Table 133. GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 134. GNS Healthcare Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 135. GNS Healthcare Recent Developments
Table 136. Genpact Company Details
Table 137. Genpact Business Overview
Table 138. Genpact Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 139. Genpact Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 140. Genpact Recent Developments
Table 141. Biovista Company Details
Table 142. Biovista Business Overview
Table 143. Biovista Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 144. Biovista Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 145. Biovista Recent Developments
Table 146. NuMedii Company Details
Table 147. NuMedii Business Overview
Table 148. NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 149. NuMedii Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 150. NuMedii Recent Developments
Table 151. BenevolentAI Company Details
Table 152. BenevolentAI Business Overview
Table 153. BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 154. BenevolentAI Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 155. BenevolentAI Recent Developments
Table 156. BERG Company Details
Table 157. BERG Business Overview
Table 158. BERG Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 159. BERG Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 160. BERG Recent Developments
Table 161. Schrцdinge Company Details
Table 162. Schrцdinge Business Overview
Table 163. Schrцdinge Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 164. Schrцdinge Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 165. Schrцdinge Recent Developments
Table 166. Nuritas Company Details
Table 167. Nuritas Business Overview
Table 168. Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 169. Nuritas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 170. Nuritas Recent Developments
Table 171. Exscientia Company Details
Table 172. Exscientia Business Overview
Table 173. Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 174. Exscientia Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 175. Exscientia Recent Developments
Table 176. Kairntech Company Details
Table 177. Kairntech Business Overview
Table 178. Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 179. Kairntech Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 180. Kairntech Recent Developments
Table 181. Concerto HealthAI (SymphonyAI) Company Details
Table 182. Concerto HealthAI (SymphonyAI) Business Overview
Table 183. Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 184. Concerto HealthAI (SymphonyAI) Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 185. Concerto HealthAI (SymphonyAI) Recent Developments
Table 186. NVIDIA Corporation Company Details
Table 187. NVIDIA Corporation Business Overview
Table 188. NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 189. NVIDIA Corporation Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 190. NVIDIA Corporation Recent Developments
Table 191. Sirenas Company Details
Table 192. Sirenas Business Overview
Table 193. Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 194. Sirenas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 195. Sirenas Recent Developments
Table 196. Standigm Company Details
Table 197. Standigm Business Overview
Table 198. Standigm Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 199. Standigm Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 200. Standigm Recent Developments
Table 201. Transcriptic Company Details
Table 202. Transcriptic Business Overview
Table 203. Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 204. Transcriptic Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 205. Transcriptic Recent Developments
Table 206. Cloud Pharmaceuticals Company Details
Table 207. Cloud Pharmaceuticals Business Overview
Table 208. Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 209. Cloud Pharmaceuticals Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 210. Cloud Pharmaceuticals Recent Developments
Table 211. Cyclica Company Details
Table 212. Cyclica Business Overview
Table 213. Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 214. Cyclica Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 215. Cyclica Recent Developments
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
Table 1. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Software
Table 3. Key Players of System
Table 4. Key Players of Service
Table 5. Key Players of Product
Table 6. Key Players of Others
Table 7. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region (2018-2023)
Table 11. Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region (2024-2029)
Table 13. Drug Developing Platforms by Artificial Intelligence (AI) Market Trends
Table 14. Drug Developing Platforms by Artificial Intelligence (AI) Market Drivers
Table 15. Drug Developing Platforms by Artificial Intelligence (AI) Market Challenges
Table 16. Drug Developing Platforms by Artificial Intelligence (AI) Market Restraints
Table 17. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Share by Players (2018-2023)
Table 19. Global Top Drug Developing Platforms by Artificial Intelligence (AI) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Developing Platforms by Artificial Intelligence (AI) as of 2022)
Table 20. Global Drug Developing Platforms by Artificial Intelligence (AI) Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Drug Developing Platforms by Artificial Intelligence (AI) Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Headquarters and Area Served
Table 23. Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Product and Application
Table 24. Global Key Players of Drug Developing Platforms by Artificial Intelligence (AI), Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Type (2018-2023)
Table 28. Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Market Share by Type (2024-2029)
Table 30. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Share by Application (2018-2023)
Table 32. Global Drug Developing Platforms by Artificial Intelligence (AI) Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Share by Application (2024-2029)
Table 34. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size by Country (2024-2029) & (US$ Million)
Table 66. Antidote Company Details
Table 67. Antidote Business Overview
Table 68. Antidote Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 69. Antidote Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 70. Antidote Recent Developments
Table 71. Atomwise Company Details
Table 72. Atomwise Business Overview
Table 73. Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 74. Atomwise Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 75. Atomwise Recent Developments
Table 76. Turbine Company Details
Table 77. Turbine Business Overview
Table 78. Turbine Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 79. Turbine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 80. Turbine Recent Developments
Table 81. Cambridge Cancer Genomics Company Details
Table 82. Cambridge Cancer Genomics Business Overview
Table 83. Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 84. Cambridge Cancer Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 85. Cambridge Cancer Genomics Recent Developments
Table 86. Row Analytics Company Details
Table 87. Row Analytics Business Overview
Table 88. Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 89. Row Analytics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 90. Row Analytics Recent Developments
Table 91. Deep Genomics Company Details
Table 92. Deep Genomics Business Overview
Table 93. Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 94. Deep Genomics Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 95. Deep Genomics Recent Developments
Table 96. Insilico Medicine Company Details
Table 97. Insilico Medicine Business Overview
Table 98. Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 99. Insilico Medicine Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 100. Insilico Medicine Recent Developments
Table 101. IBM Company Details
Table 102. IBM Business Overview
Table 103. IBM Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 104. IBM Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 105. IBM Recent Developments
Table 106. Microsoft Company Details
Table 107. Microsoft Business Overview
Table 108. Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 109. Microsoft Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 110. Microsoft Recent Developments
Table 111. Google Company Details
Table 112. Google Business Overview
Table 113. Google Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 114. Google Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 115. Google Recent Developments
Table 116. AiCure Company Details
Table 117. AiCure Business Overview
Table 118. AiCure Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 119. AiCure Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 120. AiCure Recent Developments
Table 121. Calico Company Details
Table 122. Calico Business Overview
Table 123. Calico Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 124. Calico Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 125. Calico Recent Developments
Table 126. Iktos Company Details
Table 127. Iktos Business Overview
Table 128. Iktos Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 129. Iktos Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 130. Iktos Recent Developments
Table 131. GNS Healthcare Company Details
Table 132. GNS Healthcare Business Overview
Table 133. GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 134. GNS Healthcare Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 135. GNS Healthcare Recent Developments
Table 136. Genpact Company Details
Table 137. Genpact Business Overview
Table 138. Genpact Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 139. Genpact Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 140. Genpact Recent Developments
Table 141. Biovista Company Details
Table 142. Biovista Business Overview
Table 143. Biovista Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 144. Biovista Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 145. Biovista Recent Developments
Table 146. NuMedii Company Details
Table 147. NuMedii Business Overview
Table 148. NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 149. NuMedii Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 150. NuMedii Recent Developments
Table 151. BenevolentAI Company Details
Table 152. BenevolentAI Business Overview
Table 153. BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 154. BenevolentAI Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 155. BenevolentAI Recent Developments
Table 156. BERG Company Details
Table 157. BERG Business Overview
Table 158. BERG Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 159. BERG Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 160. BERG Recent Developments
Table 161. Schrцdinge Company Details
Table 162. Schrцdinge Business Overview
Table 163. Schrцdinge Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 164. Schrцdinge Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 165. Schrцdinge Recent Developments
Table 166. Nuritas Company Details
Table 167. Nuritas Business Overview
Table 168. Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 169. Nuritas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 170. Nuritas Recent Developments
Table 171. Exscientia Company Details
Table 172. Exscientia Business Overview
Table 173. Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 174. Exscientia Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 175. Exscientia Recent Developments
Table 176. Kairntech Company Details
Table 177. Kairntech Business Overview
Table 178. Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 179. Kairntech Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 180. Kairntech Recent Developments
Table 181. Concerto HealthAI (SymphonyAI) Company Details
Table 182. Concerto HealthAI (SymphonyAI) Business Overview
Table 183. Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 184. Concerto HealthAI (SymphonyAI) Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 185. Concerto HealthAI (SymphonyAI) Recent Developments
Table 186. NVIDIA Corporation Company Details
Table 187. NVIDIA Corporation Business Overview
Table 188. NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 189. NVIDIA Corporation Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 190. NVIDIA Corporation Recent Developments
Table 191. Sirenas Company Details
Table 192. Sirenas Business Overview
Table 193. Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 194. Sirenas Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 195. Sirenas Recent Developments
Table 196. Standigm Company Details
Table 197. Standigm Business Overview
Table 198. Standigm Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 199. Standigm Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 200. Standigm Recent Developments
Table 201. Transcriptic Company Details
Table 202. Transcriptic Business Overview
Table 203. Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 204. Transcriptic Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 205. Transcriptic Recent Developments
Table 206. Cloud Pharmaceuticals Company Details
Table 207. Cloud Pharmaceuticals Business Overview
Table 208. Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 209. Cloud Pharmaceuticals Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 210. Cloud Pharmaceuticals Recent Developments
Table 211. Cyclica Company Details
Table 212. Cyclica Business Overview
Table 213. Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Product
Table 214. Cyclica Revenue in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023) & (US$ Million)
Table 215. Cyclica Recent Developments
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type: 2022 VS 2029
Figure 3. Software Features
Figure 4. System Features
Figure 5. Service Features
Figure 6. Product Features
Figure 7. Others Features
Figure 8. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application: 2022 VS 2029
Figure 10. Generate Data and Models Case Studies
Figure 11. Repurpose Existing Drugs Case Studies
Figure 12. Generate Novel Drug Candidates Case Studies
Figure 13. Validate and Optimize Drug Candidates Case Studies
Figure 14. Design Drugs Case Studies
Figure 15. Others Case Studies
Figure 16. Drug Developing Platforms by Artificial Intelligence (AI) Report Years Considered
Figure 17. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region: 2022 VS 2029
Figure 20. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Players in 2022
Figure 21. Global Top Drug Developing Platforms by Artificial Intelligence (AI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Developing Platforms by Artificial Intelligence (AI) as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Drug Developing Platforms by Artificial Intelligence (AI) Revenue in 2022
Figure 23. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 25. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 26. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Country (2018-2029)
Figure 27. United States Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 30. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 31. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 32. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Country (2018-2029)
Figure 33. Germany Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. France Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. U.K. Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Italy Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Russia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Nordic Countries Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 40. China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 41. China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 42. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 43. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 44. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 45. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region (2018-2029)
Figure 46. Japan Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. South Korea Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. China Taiwan Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. India Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Australia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 54. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 55. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Country (2018-2029)
Figure 56. Brazil Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Mexico Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Turkey Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Israel Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. GCC Countries Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. Antidote Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 63. Atomwise Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 64. Turbine Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 65. Cambridge Cancer Genomics Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 66. Row Analytics Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 67. Deep Genomics Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 68. Insilico Medicine Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 69. IBM Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 70. Microsoft Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 71. Google Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 72. AiCure Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 73. Calico Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 74. Iktos Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 75. GNS Healthcare Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 76. Genpact Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 77. Biovista Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 78. NuMedii Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 79. BenevolentAI Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 80. BERG Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 81. Schrцdinge Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 82. Nuritas Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 83. Exscientia Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 84. Kairntech Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 85. Concerto HealthAI (SymphonyAI) Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 86. NVIDIA Corporation Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 87. Sirenas Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 88. Standigm Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 89. Transcriptic Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 90. Cloud Pharmaceuticals Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 91. Cyclica Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Figure 1. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type: 2022 VS 2029
Figure 3. Software Features
Figure 4. System Features
Figure 5. Service Features
Figure 6. Product Features
Figure 7. Others Features
Figure 8. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application: 2022 VS 2029
Figure 10. Generate Data and Models Case Studies
Figure 11. Repurpose Existing Drugs Case Studies
Figure 12. Generate Novel Drug Candidates Case Studies
Figure 13. Validate and Optimize Drug Candidates Case Studies
Figure 14. Design Drugs Case Studies
Figure 15. Others Case Studies
Figure 16. Drug Developing Platforms by Artificial Intelligence (AI) Report Years Considered
Figure 17. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region: 2022 VS 2029
Figure 20. Global Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Players in 2022
Figure 21. Global Top Drug Developing Platforms by Artificial Intelligence (AI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Developing Platforms by Artificial Intelligence (AI) as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Drug Developing Platforms by Artificial Intelligence (AI) Revenue in 2022
Figure 23. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 25. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 26. North America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Country (2018-2029)
Figure 27. United States Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 30. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 31. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 32. Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Country (2018-2029)
Figure 33. Germany Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. France Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. U.K. Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Italy Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Russia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Nordic Countries Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. China Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 40. China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 41. China Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 42. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 43. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 44. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 45. Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Region (2018-2029)
Figure 46. Japan Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. South Korea Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. China Taiwan Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. India Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Australia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Type (2018-2029)
Figure 54. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Application (2018-2029)
Figure 55. Middle East, Africa, and Latin America Drug Developing Platforms by Artificial Intelligence (AI) Market Share by Country (2018-2029)
Figure 56. Brazil Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Mexico Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Turkey Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Israel Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. GCC Countries Drug Developing Platforms by Artificial Intelligence (AI) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. Antidote Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 63. Atomwise Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 64. Turbine Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 65. Cambridge Cancer Genomics Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 66. Row Analytics Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 67. Deep Genomics Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 68. Insilico Medicine Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 69. IBM Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 70. Microsoft Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 71. Google Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 72. AiCure Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 73. Calico Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 74. Iktos Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 75. GNS Healthcare Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 76. Genpact Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 77. Biovista Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 78. NuMedii Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 79. BenevolentAI Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 80. BERG Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 81. Schrцdinge Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 82. Nuritas Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 83. Exscientia Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 84. Kairntech Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 85. Concerto HealthAI (SymphonyAI) Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 86. NVIDIA Corporation Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 87. Sirenas Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 88. Standigm Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 89. Transcriptic Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 90. Cloud Pharmaceuticals Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 91. Cyclica Revenue Growth Rate in Drug Developing Platforms by Artificial Intelligence (AI) Business (2018-2023)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
